Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) has issued an announcement.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. held its 2024 annual general meeting on May 22, 2025, where all resolutions were overwhelmingly approved by shareholders. Key resolutions included the approval of the 2024 work report, financial budget for 2025, re-appointment of auditors, and amendments to the company’s articles of association. The meeting’s outcomes reflect strong shareholder support and are likely to positively impact the company’s strategic direction and governance.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the medical technology industry, focusing on developing and providing advanced medical solutions.
Average Trading Volume: 1,086,696
Technical Sentiment Signal: Buy
For a thorough assessment of 2291 stock, go to TipRanks’ Stock Analysis page.